Literature DB >> 14668717

Androgen-secreting adrenal tumors.

Fernando Cordera1, Clive Grant, Jon van Heerden, Geoffrey Thompson, William Young.   

Abstract

BACKGROUND: Adrenal tumors that secrete androgens exclusively are extraordinarily rare. The aim of this study was to characterize patients with pure androgen-secreting adrenal tumors.
METHODS: A retrospective chart review from January 1946 through November 2002 identified 11 female patients with pure androgen-secreting adrenal tumors.
RESULTS: The mean age was 23.4 years (range, 1-52). The most common presenting symptoms were hirsutism, acne, and clitoral enlargement. Elevated 17-ketosteroids were found in seven of nine tested patients. Computed tomogram, ultrasound, or both localized tumors in six of seven patients. All tumors were surgically resected, one laparoscopically, all without complications. Five of the 11 tumors were malignant. Mean weight and mean maximal diameter for benign and malignant tumors were 44 g and 4.2 cm and 232 g and 9.8 cm, respectively. Mean hospital stay was 8.5 days, with excess androgen production resolved in all patients. Recurrence and disease-related death occurred in only one patient who had pulmonary metastases at diagnosis. The remaining patients had no recurrence of tumor at mean follow-up of 11.7 years (range, 0.5-32 years).
CONCLUSIONS: Pure androgen-producing tumors are extremely rare. Approximately 50% are benign, and surgical resection provides excellent treatment if the tumors are not metastatic at the time of diagnosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14668717     DOI: 10.1016/s0039-6060(03)00410-0

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  15 in total

1.  [Acne conglobata in adrenal adenoma].

Authors:  T Wiederholt; M Megahed
Journal:  Hautarzt       Date:  2007-11       Impact factor: 0.751

Review 2.  Neuroendocrine causes of amenorrhea--an update.

Authors:  Lindsay T Fourman; Pouneh K Fazeli
Journal:  J Clin Endocrinol Metab       Date:  2015-01-12       Impact factor: 5.958

3.  Androgen secreting giant adrenocortical carcinoma with no metastases: A case report and review of the literature.

Authors:  Fatih Uruc; Ahmet Urkmez; Ozgur Haki Yuksel; Aytac Sahin; Ayhan Verit
Journal:  Can Urol Assoc J       Date:  2015-09-09       Impact factor: 1.862

4.  Increased 3β-hydroxysteroid dehydrogenase 2 and 17α-hydroxylase activities in a virilized adolescent female with adrenal adenoma: A case report.

Authors:  Guoqing Yang; Jingtao Dou; Xiaolin Zhang; Weijun Gu; Zhaohui Lv; Jin DU; Jianming Ba; Yiming Mu; Juming Lu
Journal:  Exp Ther Med       Date:  2015-12-14       Impact factor: 2.447

5.  Adrenocortical carcinoma with skeletal metastases in a postmenopausal woman.

Authors:  Shila Mitra; Suparna Ghosh Roy; Prabir Kumar Sur
Journal:  Indian J Med Paediatr Oncol       Date:  2009-01

6.  Two patients with marginal symptoms showing hyperthecosis at the edge of malignancy: Presentation of two cases.

Authors:  Sinan Beksac; Ilker Selçuk; Gökhan Boyraz; Güneş Güner; Mert Turgal; Alp Usubutun
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-07-10

7.  Normal delivery following resection of an androgen-secreting adrenal carcinoma.

Authors:  Toshiyasu Amano; Tetsuya Imao; Masaya Seki; Katsurou Takemae; Keishi Yamauchi; Satoru Hata
Journal:  Reprod Med Biol       Date:  2010-11-26

8.  The prevalence of heterozygous CYP21A2 deficiency in patients with idiopathic acne, hirsutism, or both.

Authors:  Yinjie Gao; Bingqing Yu; Jiangfeng Mao; Xi Wang; Min Nie; Xueyan Wu
Journal:  Endocrine       Date:  2019-10-11       Impact factor: 3.633

Review 9.  Postmenopausal Hyperandrogenism: Evaluation and Treatment Strategies.

Authors:  Adnin Zaman; Micol S Rothman
Journal:  Endocrinol Metab Clin North Am       Date:  2021-01-11       Impact factor: 4.741

10.  Pure androgen-secreting adrenal adenoma associated with resistant hypertension.

Authors:  René Rodríguez-Gutiérrez; Mario Arturo Bautista-Medina; Ana Eugenia Teniente-Sanchez; Maria Azucena Zapata-Rivera; Juan Montes-Villarreal
Journal:  Case Rep Endocrinol       Date:  2013-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.